Business Description
Sartorius AG
ISIN : DE0007165631
Share Class Description:
HAM:SRT3: Vorz-Inhaber-Akt ohne StimmrechtDescription
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 1.95 | |||||
Debt-to-EBITDA | 6.06 | |||||
Interest Coverage | 2.42 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.81 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 42.7 | |||||
3-Year EBITDA Growth Rate | 40.7 | |||||
3-Year EPS without NRI Growth Rate | -13.8 | |||||
3-Year FCF Growth Rate | 29.4 | |||||
3-Year Book Growth Rate | 26.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 22.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.64 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.25 | |||||
9-Day RSI | 27.46 | |||||
14-Day RSI | 29.72 | |||||
6-1 Month Momentum % | -21.94 | |||||
12-1 Month Momentum % | -11.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.02 | |||||
Quick Ratio | 1.28 | |||||
Cash Ratio | 0.84 | |||||
Days Inventory | 226 | |||||
Days Sales Outstanding | 43.06 | |||||
Days Payable | 96.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.34 | |||||
Dividend Payout Ratio | 0.34 | |||||
3-Year Dividend Growth Rate | 59.9 | |||||
Forward Dividend Yield % | 0.34 | |||||
5-Year Yield-on-Cost % | 1.08 | |||||
Shareholder Yield % | -17.24 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 45.1 | |||||
Operating Margin % | 14.7 | |||||
Net Margin % | 4.49 | |||||
FCF Margin % | 4.35 | |||||
ROE % | 6.9 | |||||
ROA % | 1.68 | |||||
ROIC % | 4.74 | |||||
ROC (Joel Greenblatt) % | 19.29 | |||||
ROCE % | 6.67 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 82.19 | |||||
Forward PE Ratio | 37.45 | |||||
PE Ratio without NRI | 82.19 | |||||
Shiller PE Ratio | 50.63 | |||||
Price-to-Owner-Earnings | 51.17 | |||||
PEG Ratio | 1.65 | |||||
PS Ratio | 3.67 | |||||
PB Ratio | 4.57 | |||||
Price-to-Free-Cash-Flow | 83.26 | |||||
Price-to-Operating-Cash-Flow | 17.4 | |||||
EV-to-EBIT | 35.78 | |||||
EV-to-Forward-EBIT | 26.8 | |||||
EV-to-EBITDA | 20.6 | |||||
EV-to-Forward-EBITDA | 17.43 | |||||
EV-to-Revenue | 5.33 | |||||
EV-to-Forward-Revenue | 4.96 | |||||
EV-to-FCF | 122.47 | |||||
Price-to-Projected-FCF | 2.34 | |||||
Price-to-DCF (Earnings Based) | 2.62 | |||||
Price-to-DCF (FCF Based) | 2.66 | |||||
Price-to-Median-PS-Value | 0.72 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.29 | |||||
Earnings Yield (Greenblatt) % | 2.79 | |||||
FCF Yield % | 1.06 | |||||
Forward Rate of Return (Yacktman) % | 22.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sartorius AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3,312.1 | ||
EPS (TTM) (€) | 2.173 | ||
Beta | 2.1 | ||
Volatility % | 55.14 | ||
14-Day RSI | 29.72 | ||
14-Day ATR (€) | 6.738291 | ||
20-Day SMA (€) | 239.96 | ||
12-1 Month Momentum % | -11.5 | ||
52-Week Range (€) | 210 - 382.8 | ||
Shares Outstanding (Mil) | 68.42 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sartorius AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sartorius AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Sartorius AG Frequently Asked Questions
What is Sartorius AG(HAM:SRT3)'s stock price today?
The current price of HAM:SRT3 is €216.60. The 52 week high of HAM:SRT3 is €382.80 and 52 week low is €210.00.
When is next earnings date of Sartorius AG(HAM:SRT3)?
The next earnings date of Sartorius AG(HAM:SRT3) is 2024-07-19.
Does Sartorius AG(HAM:SRT3) pay dividends? If so, how much?
The Dividend Yield %  of Sartorius AG(HAM:SRT3) is 0.34% (As of Today), Highest Dividend Payout Ratio of Sartorius AG(HAM:SRT3) was 0.61. The lowest was 0.08. And the median was 0.21. The  Forward Dividend Yield % of Sartorius AG(HAM:SRT3) is 0.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |